In this issue:
Trial of fingolimod vs IFN β-1a in paediatrics MS
Ibudilast in progressive MS
Inclusion of ON involvement in DIS criteria for MS
Hypertension and heart disease are associated with brain atrophy in MS
CSF immunoglobulin light chain ratios predict MS disease progression
DMTs for MS and infection risk
Barriers to help-seeking for sexual dysfunction in MS
2017 revisions of McDonald criteria shorten the time to diagnosis of MS in CIS
Predicting cognitive decline in MS
Impact of silent lesions on MRI on treatment decisions in MS
Please login below to download this issue (PDF)